Search - tctmd.com

Displaying 761 - 780 of 1053

Sort: Relevancy | Date

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

Presentation TCT 2018

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

September 22, 2018

Presentation TCT 2018

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

Presenter: Allan Schwartz, Stephan Windecker, Jeffrey J. Popma

September 22, 2018

Presentation TCT 2018

NO The Data are Inconclusive and the Costs are Prohibitive!

Presenter: John K. Forrest

September 22, 2018

Presentation TCT 2018

YES Review of ALL the Data and Common Sense Tell the Story!

Presenter: Susheel K. Kodali

September 22, 2018

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

Cedars-Sinai Medical Center (USA

Presenter: Tarun Chakravarty

September 22, 2018

Presentation TCT 2018

Erasmus University (The Netherlands)

Presenter: Herbert Kroon

September 22, 2018

Presentation TCT 2018

Ulm University (Germany)

Presenter: Jochen Wöhrle

September 22, 2018

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

Case-Based Discussion on BAV Rapid-Fire Presentation of 3 BAV Cases

Presenter: Joseph E. Bavaria, Horst Sievert, Jung-Min Ahn, Stanley J. Chetcuti, Helene Eltchaninoff, Hasan Jilaihawi, John C Laschinger, Jonathon A. Leipsic, Mathew Williams

September 22, 2018

Presentation TCT 2018

TAVR Outcomes for BAV in Asian Patients

Presenter: Joseph E. Bavaria, Horst Sievert, Jung-Min Ahn

September 22, 2018

Presentation TCT 2018

Device Selection and CT Sizing for TAVR Treatment of BAV

Presenter: Joseph E. Bavaria, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Presenter: Joseph E. Bavaria, Horst Sievert, Hasan Jilaihawi

September 22, 2018

Presentation TCT 2018

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

Presenter: Joseph E. Bavaria, Horst Sievert, Mathew Williams

September 22, 2018

Presentation TCT 2018

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

Presenter: Joseph E. Bavaria, Horst Sievert, Jonathon A. Leipsic

September 22, 2018

Presentation TCT 2018

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

Presenter: Joseph E. Bavaria, Horst Sievert

September 22, 2018

Presentation TCT 2018

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

Presenter: Jacques Busquet, Virendra I Patel, Michael Zhadkevich

September 21, 2018

Presentation TCT 2018

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

September 21, 2018

Presentation TCT 2018

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

Presenter: Gerardo Nau

September 21, 2018

Advertisement

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

My Crystal Ball - Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis Once the Cycle of Low-Risk Studies is Completed

The Case for TAVR in Low-Risk Patients: Rationale, Current Data, Clinical Trends, and Updates from the Ongoing Clinical Trials

NO The Data are Inconclusive and the Costs are Prohibitive!

YES Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Cedars-Sinai Medical Center (USA

Erasmus University (The Netherlands)

Ulm University (Germany)

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Case-Based Discussion on BAV Rapid-Fire Presentation of 3 BAV Cases

TAVR Outcomes for BAV in Asian Patients

Device Selection and CT Sizing for TAVR Treatment of BAV

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

TCT-88: Optimal Cerebral Protection in Cardiac and Aortic Interventions: Vascular Filters vs. Balloon Occlusion?

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Debate Pro: TAVR for Moderate-Risk Patients: Ready for Prime Time!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content